{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:29:51Z","timestamp":1793168991222,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H01684"],"award-info":[{"award-number":["17H01684"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Schistosomes are trematode worms that dwell in their definitive host\u2019s blood vessels, where females lay eggs that need to be discharged into the environment with host excreta to maintain their life-cycle. Both worms and eggs require type 2 immunity for their maturation and excretion, respectively. However, the immune molecules that orchestrate such immunity remain unclear. Interleukin (IL)-33 is one of the epithelium-derived cytokines that induce type 2 immunity in tissues. The aim of this study was to determine the role of IL-33 in the maturation, reproduction and excretion of\n                      <jats:italic>Schistosoma mansoni<\/jats:italic>\n                      eggs, and in the maintenance of egg-induced pathology in the intestines of mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The morphology of\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      worms and the number of eggs in intestinal tissues were studied at different time points post-infection in\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      -infected IL-33-deficient (IL-33\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      ) and wild-type (WT) mice. IL-5 and IL-13 production in the spleens and mesenteric lymph nodes were measured. Tissue histology was performed on the terminal ilea of both infected and non-infected mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Worms from IL-33\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      and WT mice did not differ morphologically at 4 and 6 weeks post-infection (wpi). The\u00a0number of eggs in intestinal tissues of IL-33\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      and WT mice differed only slightly. At 6 wpi, IL-33\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice presented impaired type 2 immunity in the intestines, characterized by a decreased production of IL-5 and IL-13 in mesenteric lymph nodes and fewer inflammatory infiltrates with fewer eosinophils in the ilea. There was no difference between IL-33\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      and WT mice in the levels of IL-25 and thymic stromal lymphopoietin (TSLP) in intestinal tissues.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Despite its ability to initiate type 2 immunity in tissues, IL-33 alone seems dispensable for\n                      <jats:italic>S. mansoni<\/jats:italic>\n                      maturation and its absence may not affect much the accumulation of eggs in intestinal tissues. The transient impairment of type 2 immunity observed in the intestines, but not spleens, highlights the importance of IL-33 over IL-25 and TSLP in initiating, but not maintaining, locally-induced type 2 immunity in intestinal tissues during schistosome infection. Further studies are needed to decipher the role of each of these molecules in schistosomiasis and clarify the possible interactions that might exist between them.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-020-04561-w","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T01:02:58Z","timestamp":1611277378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Interleukin (IL)-33 is dispensable for Schistosoma mansoni worm maturation and the maintenance of egg-induced pathology in intestines of infected mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Jean Pierre Kambala","family":"Mukendi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-8337","authenticated-orcid":false,"given":"Shinjiro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"4561_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou X-N. Schistosomiasis. Nat Rev Dis Prim. 2018;4:13.","journal-title":"Nat Rev Dis Prim"},{"key":"4561_CR2","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253\u201364.","journal-title":"Lancet"},{"key":"4561_CR3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368:1106\u201318.","journal-title":"Lancet"},{"key":"4561_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4269\/ajtmh.1956.5.831","volume":"5","author":"DV Moore","year":"1956","unstructured":"Moore DV, Sandground JH. The relative egg producing capacity of Schistosoma mansoni and Schistosoma japonicum. Am J Trop Med Hyg. 1956;5:831\u201340.","journal-title":"Am J Trop Med Hyg"},{"key":"4561_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4269\/ajtmh.1994.50.281","volume":"50","author":"AW Cheever","year":"1994","unstructured":"Cheever AW, Macedonia JG, Mosimann JE, Cheever EA. Kinetics of egg production and egg excretion by Schistosoma mansoni and S. japonicum in mice infected with a single pair of worms. Am J Trop Med Hyg. 1994;50:281\u201395.","journal-title":"Am J Trop Med Hyg"},{"key":"4561_CR6","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1074\/jbc.M300497200","volume":"278","author":"G Schramm","year":"2003","unstructured":"Schramm G, Falcone FH, Gronow A, Haisch K, Mamat U, Doenhoff MJ, et al. Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs. J Biol Chem. 2003;278:18384\u201392.","journal-title":"J Biol Chem"},{"key":"4561_CR7","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.4049\/jimmunol.178.10.6023","volume":"178","author":"G Schramm","year":"2007","unstructured":"Schramm G, Mohrs K, Wodrich M, Doenhoff MJ, Pearce EJ, Haas H, et al. Cutting edge: IPSE\/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo. J Immunol. 2007;178:6023\u20137.","journal-title":"J Immunol"},{"key":"4561_CR8","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1084\/jem.20082460","volume":"206","author":"B Everts","year":"2009","unstructured":"Everts B, Perona-Wright G, Smits HH, Hokke CH, van der Ham AJ, Fitzsimmons CM, et al. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med. 2009;206:1673\u201380.","journal-title":"J Exp Med"},{"key":"4561_CR9","doi-asserted-by":"publisher","first-page":"e00301-17","DOI":"10.1128\/IAI.00301-17","volume":"85","author":"LF Pennington","year":"2017","unstructured":"Pennington LF, Alouffi A, Mbanefo EC, Ray D, Heery DM, Jardtzky TS, et al. H-IPSE is a pathogen-secreted host nucleus-infiltrating protein (infiltrin) expressed exclusively by the Schistosoma haematobium egg stage. Infect Immun. 2017;85:e00301-17.","journal-title":"Infect Immun"},{"key":"4561_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13071-016-1962-y","volume":"10","author":"XD Ke","year":"2017","unstructured":"Ke XD, Shen S, Song LJ, Yu CX, Kikuchi M, Hirayama K, et al. Characterization of Schistosoma japonicum CP1412 protein as a novel member of the ribonuclease T2 molecule family with immune regulatory function. Parasites Vectors. 2017;10:89.","journal-title":"Parasites Vectors"},{"key":"4561_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri843","volume":"2","author":"EJ Pearce","year":"2002","unstructured":"Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2:499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"4561_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.icb.7100014","volume":"85","author":"MS Wilson","year":"2007","unstructured":"Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol. 2007;85:148\u201354.","journal-title":"Immunol Cell Biol"},{"key":"4561_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fimmu.2013.00089","volume":"4","author":"E Hams","year":"2013","unstructured":"Hams E, Aviello G, Fallon PG. The Schistosoma granuloma: friend or foe? Front Immunol. 2013;4:89.","journal-title":"Front Immunol"},{"key":"4561_CR14","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4049\/jimmunol.164.5.2585","volume":"164","author":"PG Fallon","year":"2000","unstructured":"Fallon PG, Richardson EJ, McKenzie GJ, McKenzie ANJ. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol. 2000;164:2585\u201391.","journal-title":"J Immunol"},{"key":"4561_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","volume":"20","author":"DR Herbert","year":"2004","unstructured":"Herbert DR, H\u00f6lscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20:623\u201335.","journal-title":"Immunity"},{"key":"4561_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1086\/649841","volume":"201","author":"LA de Oliveira Fraga","year":"2010","unstructured":"de Oliveira Fraga LA, Torrero MN, Tocheva AS, Mitre E, Davies SJ. Induction of type 2 responses by schistosome worms during prepatent infection. J Infect Dis. 2010;201:464\u201372.","journal-title":"J Infect Dis"},{"key":"4561_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2172-11-56","volume":"11","author":"LA de Oliveira Fraga","year":"2010","unstructured":"de Oliveira Fraga LA, Lamb EW, Moreno EC, Chatterjee M, Dvo\u0159\u00e1k J, Delcroix M, et al. Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection. BMC Immunol. 2010;11:56.","journal-title":"BMC Immunol"},{"key":"4561_CR18","doi-asserted-by":"publisher","first-page":"e1003708","DOI":"10.1371\/journal.ppat.1003708","volume":"9","author":"DK Riner","year":"2013","unstructured":"Riner DK, Ferragine CE, Maynard SK, Davies SJ. Regulation of innate responses during pre-patent schistosome infection provides an immune environment permissive for parasite development. PLoS Pathog. 2013;9:e1003708.","journal-title":"PLoS Pathog"},{"key":"4561_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of Th2 cytokines by adipose tissue-associated c-Kit+ Sca-1+ lymphoid cells. Nature. 2010;463:540\u20134.","journal-title":"Nature"},{"key":"4561_CR20","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/mi.2016.4","volume":"9","author":"VS Pelly","year":"2016","unstructured":"Pelly VS, Kannan Y, Coomes SM, Entwistle LJ, R\u00fcckerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of Th2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407\u201317.","journal-title":"Mucosal Immunol"},{"key":"4561_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2016.02.030","volume":"138","author":"M Noval Rivas","year":"2016","unstructured":"Noval Rivas M, Burton OT, Oettgen HC, Chatila T. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J Allergy Clin Immunol. 2016;138:801\u201311.","journal-title":"J Allergy Clin Immunol"},{"key":"4561_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","volume":"464","author":"DR Neill","year":"2010","unstructured":"Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464:1367\u201370.","journal-title":"Nature"},{"key":"4561_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","volume":"41","author":"CJ Oliphant","year":"2014","unstructured":"Oliphant CJ, Hwang YY, Walker JA, Salimi M, Wong SH, Brewer JM, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity. 2014;41:283\u201395.","journal-title":"Immunity"},{"key":"4561_CR24","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.immuni.2018.05.003","volume":"48","author":"TYF Halim","year":"2018","unstructured":"Halim TYF, Rana BMJ, Walker JA, Kerscher B, Knolle MD, Jolin HE, et al. Tissue-restricted adaptive type 2 immunity is orchestrated by expression of the costimulatory molecule OX40L on group 2 innate lymphoid cells. Immunity. 2018;48:1195\u2013207.","journal-title":"Immunity"},{"key":"4561_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","volume":"40","author":"TYF Halim","year":"2014","unstructured":"Halim TYF, Steer CA, Math\u00e4 L, Gold MJ, Martinez-Gonzalez I, McNagny KM, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity. 2014;40:425\u201335.","journal-title":"Immunity"},{"key":"4561_CR26","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s00436-015-4492-1","volume":"114","author":"Y Yu","year":"2015","unstructured":"Yu Y, Deng W, Lei J. Interleukin-33 promotes Th2 immune responses in infected mice with Schistosoma japonicum. Parasitol Res. 2015;114:2911\u20138.","journal-title":"Parasitol Res"},{"key":"4561_CR27","doi-asserted-by":"publisher","first-page":"29844","DOI":"10.1038\/srep29844","volume":"6","author":"H Peng","year":"2016","unstructured":"Peng H, Zhang Q, Li X, Liu Z, Shen J, Sun R, et al. IL-33 contributes to Schistosoma japonicum-induced hepatic pathology through induction of M2 macrophages. Sci Rep. 2016;6:29844.","journal-title":"Sci Rep"},{"key":"4561_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","volume":"39","author":"T Mchedlidze","year":"2013","unstructured":"Mchedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M, et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity. 2013;39:357\u201371.","journal-title":"Immunity"},{"key":"4561_CR29","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.4049\/jimmunol.0901575","volume":"183","author":"M Kurowska-Stolarska","year":"2009","unstructured":"Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol. 2009;183:6469\u201377.","journal-title":"J Immunol"},{"key":"4561_CR30","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","volume":"134","author":"D Li","year":"2014","unstructured":"Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L, et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol. 2014;134:1422\u201332.","journal-title":"J Allergy Clin Immunol"},{"key":"4561_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41598-017-00840-2","volume":"7","author":"DH Seo","year":"2017","unstructured":"Seo DH, Che X, Kwak MS, Kim S, Kim JH, Ma HW, et al. Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease. Sci Rep. 2017;7:851.","journal-title":"Sci Rep"},{"key":"4561_CR32","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.4049\/jimmunol.0902009","volume":"184","author":"DBR Herbert","year":"2010","unstructured":"Herbert DBR, Orekov T, Roloson A, Ilies M, Perkins C, Brien WO, et al. Arginase I suppresses IL-12\/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol. 2010;184:6438\u201346.","journal-title":"J Immunol"},{"key":"4561_CR33","doi-asserted-by":"publisher","first-page":"e1003063","DOI":"10.1371\/journal.ppat.1003063","volume":"8","author":"JD Turner","year":"2012","unstructured":"Turner JD, Narang P, Coles MC, Mountford AP. Blood flukes exploit Peyer\u2019s patch lymphoid tissue to facilitate transmission from the mammalian host. PloS Pathog. 2012;8:e1003063.","journal-title":"PloS Pathog"},{"issue":"Suppl. 103","key":"4561_CR34","first-page":"19.1.1","volume":"2013","author":"MS Tucker","year":"2013","unstructured":"Tucker MS, Karunaratne LB, Lewis FA, Freitas TC, Liang Y. Schistosomiasis. Curr Protoc Immunol. 2013;2013(Suppl. 103):19.1.1\u201319.1.58.","journal-title":"Curr Protoc Immunol"},{"key":"4561_CR35","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1126\/science.1064462","volume":"294","author":"SJ Davies","year":"2001","unstructured":"Davies SJ, Grogan JL, Blank RB, Lim KC, Locksley RM, McKerrow JH. Modulation of blood fluke development in the liver by hepatic CD4+ lymphocytes. Science. 2001;294:1358\u201361.","journal-title":"Science"},{"key":"4561_CR36","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1073\/pnas.1112268109","volume":"109","author":"MR Hepworth","year":"2012","unstructured":"Hepworth MR, Dani\u0142owicz-Luebert E, Rausch S, Metz M, Klotz C, Maurer M, et al. Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines. Proc Natl Acad Sci USA. 2012;109:6644\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4561_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ijpara.2006.11.001","volume":"37","author":"EW Lamb","year":"2007","unstructured":"Lamb EW, Crow ET, Lim KC, Liang Y, Lewis FA, Davies SJ. Conservation of CD4+ T cell-dependent developmental mechanisms in the blood fluke pathogens of humans. Int J Parasitol. 2007;37:405\u201315.","journal-title":"Int J Parasitol"},{"key":"4561_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479\u201390.","journal-title":"Immunity"},{"key":"4561_CR39","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jaci.2013.05.012","volume":"132","author":"JL Barlow","year":"2013","unstructured":"Barlow JL, Peel S, Fox J, Panova V, Hardman CS, Camelo A, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol. 2013;132:933\u201341.","journal-title":"J Allergy Clin Immunol."},{"key":"4561_CR40","doi-asserted-by":"publisher","first-page":"e59441","DOI":"10.1371\/journal.pone.0059441","volume":"8","author":"Z Yang","year":"2013","unstructured":"Yang Z, Grinchuk V, Urban JF, Bohl J, Sun R, Notari L, et al. Macrophages as IL-25\/IL-33-responsive cells play an important role in the induction of type 2 immunity. PLoS One. 2013;8:e59441.","journal-title":"PLoS One"},{"key":"4561_CR41","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1097\/MIB.0000000000000532","volume":"21","author":"A Waddell","year":"2015","unstructured":"Waddell A, Vallance JE, Moore PD, Hummel AT, Wu D, Shanmukhappa SK, et al. IL-33 signaling protects from murine oxazolone colitis by supporting intestinal epithelial function. Inflamm Bowel Dis. 2015;21:2737\u201346.","journal-title":"Inflamm Bowel Dis"},{"key":"4561_CR42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ajpath.2015.11.028","volume":"186","author":"C De Salvo","year":"2016","unstructured":"De Salvo C, Wang XM, Pastorelli L, Mattioli B, Omenetti S, Buela KA, et al. IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis. Am J Pathol. 2016;186:885\u201398.","journal-title":"Am J Pathol"},{"key":"4561_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ni.2920","volume":"15","author":"K Gerlach","year":"2014","unstructured":"Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. Th9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676\u201386.","journal-title":"Nat Immunol"},{"key":"4561_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12931-016-0321-z","volume":"17","author":"BM Salter","year":"2016","unstructured":"Salter BM, Oliveria JP, Nusca G, Smith SG, Tworek D, Mitchell PD, et al. IL-25 and IL-33 induce type 2 inflammation in basophils from subjects with allergic asthma. Respir Res. 2016;17:5.","journal-title":"Respir Res"},{"key":"4561_CR45","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4049\/jimmunol.1700216","volume":"199","author":"M Han","year":"2017","unstructured":"Han M, Rajput C, Hong JY, Lei J, Hinde JL, Wu Q, et al. The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice. J Immunol. 2017;199:1308\u201318.","journal-title":"J Immunol"},{"key":"4561_CR46","doi-asserted-by":"publisher","first-page":"337ra65","DOI":"10.1126\/scitranslmed.aaf1938","volume":"8","author":"KM Vannella","year":"2016","unstructured":"Vannella KM, Ramalingam TR, Borthwick LA, Barron L, Hart KM, Thompson RW, et al. Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis. Sci Transl Med. 2016;8:337ra65.","journal-title":"Sci Transl Med"},{"key":"4561_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0167-5699(85)90034-9","volume":"6","author":"MJ Doenhoff","year":"1985","unstructured":"Doenhoff MJ, Hassounah OA, Lucas SB. Does the immunopathology induced by schistosome eggs potentiate parasite survival? Immunol Today. 1985;6:203\u20136.","journal-title":"Immunol Today"},{"key":"4561_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4269\/ajtmh.13-0045","volume":"89","author":"EMO Muok","year":"2013","unstructured":"Muok EMO, Simiyu EW, Ochola EA, Nganga ZW, Secor WE, Karanja DMS, et al. Short report: association between CD4+ T-lymphocyte counts and fecal excretion of Schistosoma mansoni eggs in patients coinfected with S. mansoni and human immunodeficiency virus before and after initiation of antiretroviral therapy. Am J Trop Med Hyg. 2013;89:42\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"4561_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4269\/ajtmh.1997.56.515","volume":"56","author":"DMS Karanja","year":"1997","unstructured":"Karanja DMS, Colley D, Nahlen BL, Ouma JH, Secor AE. Studies on schistosomiasis in Western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg. 1997;56:515\u201321.","journal-title":"Am J Trop Med Hyg."},{"key":"4561_CR50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1096\/fj.15-277822","volume":"30","author":"E Hams","year":"2016","unstructured":"Hams E, Bermingham R, Wurlod FA, Hogan AE, O\u2019Shea D, Preston RJ, et al. The helminth T2 RNase \u03c91 promotes metabolic homeostasis in an IL-33- and group 2 innate lymphoid cell-dependent mechanism. FASEB J. 2016;30:824\u201335.","journal-title":"FASEB J"},{"key":"4561_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1073\/pnas.1315854111","volume":"111","author":"E Hams","year":"2014","unstructured":"Hams E, Armstrong ME, Barlow JL, Saunders SP, Schwartz C, Cooke G, et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci USA. 2014;111:367\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4561_CR52","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1017\/S0031182009005708","volume":"136","author":"RA Wilson","year":"2009","unstructured":"Wilson RA. The saga of schistosome migration and attrition. Parasitology. 2009;136:1581\u201392.","journal-title":"Parasitology"},{"key":"4561_CR53","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2307\/3282399","volume":"73","author":"JR Georgi","year":"1987","unstructured":"Georgi JR, Wade SE, Dean DA. Schistosoma mansoni: mechanism of attrition and routes of migration from lungs to hepatic portal system in the laboratory mouse. J Parasitol. 1987;73:706\u201311.","journal-title":"J Parasitol"},{"key":"4561_CR54","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.4049\/jimmunol.1101977","volume":"188","author":"M Pichery","year":"2012","unstructured":"Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol. 2012;188:3488\u201395.","journal-title":"J Immunol"},{"key":"4561_CR55","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1086\/508896","volume":"194","author":"RB Blank","year":"2006","unstructured":"Blank RB, Lamb EW, Tocheva AS, Crow ET, Lim KC, McKerrow JH, et al. The common gamma chain cytokines interleukin (IL)-2 and IL-7 indirectly modulate blood fluke development via effects on CD4+ T cells. J Infect Dis. 2006;194:1609\u201316.","journal-title":"J Infect Dis"},{"key":"4561_CR56","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1128\/IAI.67.8.4183-4190.1999","volume":"67","author":"I Wolowczuk","year":"1999","unstructured":"Wolowczuk I, Nutten S, Roye O, Delacre M, Capron M, Murray RM, et al. Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni. Infect Immun. 1999;67:4183\u201390.","journal-title":"Infect Immun"},{"key":"4561_CR57","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/mi.2017.61","volume":"11","author":"H Han","year":"2018","unstructured":"Han H, Roan F, Johnston LK, Smith DE, Bryce PJ, Ziegler SF. IL-33 promotes gastrointestinal allergy in a TSLP-independent manner. Mucosal Immunol. 2018;11:394\u2013403.","journal-title":"Mucosal Immunol"},{"key":"4561_CR58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2332\/allergolint.13-OA-0672","volume":"63","author":"N Murakami-Satsutani","year":"2014","unstructured":"Murakami-Satsutani N, Ito T, Nakanishi T, Inagaki N, Tanaka A, Vien PTX, et al. IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand. Allergol Int. 2014;63:443\u201355.","journal-title":"Allergol Int"},{"key":"4561_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","volume":"31","author":"C Cayrol","year":"2014","unstructured":"Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31\u20137.","journal-title":"Curr Opin Immunol"},{"key":"4561_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard JP. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev. 2018;281:154\u201368.","journal-title":"Immunol Rev"},{"key":"4561_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.it.2015.11.003","volume":"37","author":"CH Kim","year":"2016","unstructured":"Kim CH, Hashimoto-Hill S, Kim M. Migration and tissue tropism of innate lymphoid cells. Trends Immunol. 2016;37:68\u201379.","journal-title":"Trends Immunol"},{"key":"4561_CR62","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.immuni.2020.02.009","volume":"52","author":"A Flamar","year":"2020","unstructured":"Flamar A, Klose CSN, Moeller JB, Mahlakoiv T, Bessman NJ, Zhang W, et al. Interleukin-33 induces the enzyme tryptophan hydroxylase 1 to promote inflammatory group 2 innate lymphoid cell-mediated immunity. Immunity. 2020;52:606\u201319.","journal-title":"Immunity"},{"key":"4561_CR63","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.4049\/jimmunol.1600611","volume":"197","author":"LK Johnston","year":"2016","unstructured":"Johnston LK, Hsu C-L, Krier-Burris RA, Chhiba KD, Chien KB, McKenzie A, et al. IL-33 precedes IL-5 in regulating eosinophil commitment and is required for eosinophil homeostasis. J Immunol. 2016;197:3445\u201353.","journal-title":"J Immunol"},{"key":"4561_CR64","doi-asserted-by":"publisher","first-page":"e0217807","DOI":"10.1371\/journal.pone.0217807","volume":"14","author":"EL Angulo","year":"2019","unstructured":"Angulo EL, McKernan EM, Fichtinger PS, Mathur SK. Comparison of IL-33 and IL-5 family mediated activation of human eosinophils. PLoS One. 2019;14:e0217807.","journal-title":"PLoS One"},{"key":"4561_CR65","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.1206587110","volume":"110","author":"LY Hung","year":"2013","unstructured":"Hung LY, Lewkowich IP, Dawson LA, Downey J, Yang Y, Smith DE, et al. IL-33 drives biphasic IL-13 production for noncanonical type 2 immunity against hookworms. Proc Natl Acad Sci USA. 2013;110:282\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4561_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaci.2007.06.004","volume":"120","author":"YJ Liu","year":"2007","unstructured":"Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol. 2007;120:238\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"4561_CR67","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/ni1247","volume":"6","author":"B Zhou","year":"2005","unstructured":"Zhou B, Comeau MR, de Smedt T, Liggitt HD, Dahl ME, Lewis DB, et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol. 2005;6:1047\u201353.","journal-title":"Nat Immunol"},{"key":"4561_CR68","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1084\/jem.20051615","volume":"203","author":"PG Fallon","year":"2006","unstructured":"Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, Hewett DR, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006;203:1105\u201316.","journal-title":"J Exp Med"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-020-04561-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T13:43:01Z","timestamp":1634391781000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-04561-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4561"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-04561-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-58017\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-58017\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"12 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Nagasaki University Committee for Ethics on Animal Experiments (Approval Numbers: 1505181226; 1612081349) and Recombinant DNA experiments (Approval Numbers: 1403041262; 1902201550). All the experiments followed the Nagasaki University institutional guidelines for animal experiments and the Japanese Law for Humane Treatment and Management of Animals (Law No. 105 dated 19 October 1973, modified on 2 June 2006).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}